Skip to main content

Table 3 Kansas City Cardiomyopathy Questionnaire results summary for each of the assessment domains and global KCCQ score according to NYHA functional class

From: Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire

Variable

NYHA I median (min, max)

NYHA II median (min, max)

NYHA III median (min, max)

P Jonckheere–Tepstra

Pairwise posttest comparissons

Physical limitation

95.8

(41.6–100)

64.5

(0–100)

50

(25–87.5)

0.001

1–2: p = 0.002

1–3: p = 0.001

Symptom frequency

100

(52–100)

75

(20.8–100)

64.5

(39.5–100)

0.001

1–2: p = 0.001

1–3: p = 0.001

Quality of life

87.5

(12.5–100)

50

(12.5–100)

50

(12.5–100)

0.002

1–3: p = 0.004

1–2: p = 0.018

Social limitation

100

(8.3–100)

75

(0–100)

50

(8.3–100)

0.002

1–3: p = 0.003

Global KCCQ

90.6

(35.9–100)

65.6

(19.4–100)

57.2

(30.7–88.5)

0.001

1–3: p = 0.001

1–2: p = 0.002

  1. NYHA New York Heart Association, KCCQ Kansas City Cardiomyopathy Questionnaire